NASDAQ: BCAXBicara Therapeutics Inc Stock Ownership - Who owns Bicara Therapeutics?
Insider buying vs selling
Have Bicara Therapeutics Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Lara Meisner | Chief Legal Officer | 2025-03-14 | 48,526 | $12.69 | $615.70kSell |
| Lara Meisner | Chief Legal Officer | 2025-03-14 | 79,146 | $5.45 | $431.35kSell |
| Lara Meisner | Chief Legal Officer | 2025-03-14 | 30,620 | $13.24 | $405.50kSell |
| James E. Flynn | 10% Owner | 2024-09-17 | 35,000 | $18.00 | $630.00kBuy |
| James E. Flynn | 10% Owner | 2024-09-17 | 35,000 | $18.00 | $630.00kBuy |
| Ra Capital Management LP | Director | 2024-09-16 | 1,680,520 | $18.00 | $30.25MBuy |
| Ra Capital Management LP | Director | 2024-09-16 | 152,480 | $18.00 | $2.74MBuy |
BCAX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when BCAX insiders and whales buy or sell their stock.
BCAX Shareholders
What type of owners hold Bicara Therapeutics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Ra Capital Management LP | 12.75% | 6,955,993 | $75.40M | Institution |
| Kiran Mazumdarshaw | 11.55% | 6,297,854 | $68.27M | Insider |
| Biocon Ltd | 10.13% | 5,523,897 | $59.88M | Insider |
| Fmr LLC | 6.62% | 3,611,573 | $39.15M | Institution |
| Siren LLC | 5.99% | 3,267,083 | $35.42M | Institution |
| Red Tree Management LLC | 5.81% | 3,170,509 | $34.37M | Institution |
| Tpg GP A LLC | 5.52% | 3,010,425 | $32.63M | Institution |
| Vestal Point Capital LP | 5.08% | 2,768,975 | $30.02M | Institution |
| Ra Capital Management LP | 4.86% | 2,652,575 | $28.75M | Insider |
| Omega Fund Management LLC | 4.04% | 2,204,650 | $23.90M | Institution |
BCAX vs Biotech Stocks
Bicara Therapeutics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.